Oxurion NV — Director's Dealing 2024

Oct 8, 2024

PRESS RELEASE

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Leuven, BELGIUM – October 8, 2024 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation¹ it has received a transparency notification as follows:

Oxurion received a transparency notification on October 7, 2024, from Atlas Special Opportunities, LLC indicating that as of October 7, 2024, it held 47,363 shares of the then outstanding 1,549,709 shares, and therefore crossed below the threshold (5%) by virtue of the sale of voting securities. See Annex 1.

About Oxurion

Oxurion (Euronext Brussels: OXUR) is engaged in developing next-generation standard of care ophthalmic therapies for the treatment of retinal disease. Oxurion is based in Leuven, Belgium. More information is available at www.oxurion.com.

Important information about forward-looking statements

Certain statements in this press release may be considered "forward-looking". Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forwardlooking statement is contained in the Company's Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. state securities laws.

For further information please contact:

Oxurion NV Pascal Ghoson Chief Executive Officer Pascal.ghoson@oxurion.com

________

1. Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major holdings.

ANNEX 1

1) Status of the notification
	Final
2) Issuer
	Name OXLRION
Identification number 0881-620-924
3) Reason for the notification
	Acquisition or disposal of voting securities or voting rights
4) Notification by
	A person that notifies alone
6) Remons subject to the notification requirement,
	Name		Address (for legal entities)
	Atlas Special Opportunities LLC		2500 Westchester Avenue, Suite 401, Purchase, NY 10577
6) Persons that disoose of voting rights (only to be filled in it art. 7 of the Law applies)
	Name		Address (for legal entities)
Please continue entering the information in part if concerning the Part II persons referred to in Sections 5 and 6
7) Date on which the threshold is crossed
(07/10/2024 (DD/MM/YYYY)
8) Threshold that is crossed (in %)
	5
If the holding has fallen below the lowest threshold, you have the option of not entering any numbers in Section 10
9) Denominator
	1,549,709
	Please enter the denominator before filling in the data
10) Notified details
A) Voling rights	Previous notification	After the transaction
	# of voting rights		# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Atlas Special Opportunities LLC	121,000	47,383		3.08%
	TOTAL	47,383	0	3.06%	0.00%
	Start with "groups" of holders. Add subtotals with 2, and then finish with the persons with the "alone".

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or dato	# of voting rights that may be acquired if the Instrument is exercised	% of voting rights	Settlement
							+
	TOTAL			0	0.00%

The totals will be updated once you have clicked on

TOTAL (A & B)			# of voting rights % of voting rights
	CALCULATE	47,363	3.06%

11) Full chain of controlled undertakings through which the holding is effectively held, it applicable

	Allas Special Opportunities LLC is not a controlled entity.
12) In case of proxy voting for only one GM Holder	will cease to hold / will hold again	(DDMM/YYYY) voling rights as of
13) Additional information
denominator = 1,549,709).	Con Couber 2024 (ets settiment data on 7 October 2008). Alass Copcountes LC ock 73,637 shares in Cruiter NV, as a nead of with in skenning decessed by 4,253 sharas (= 3.05,
Done at New York
்ப	07/10/2024 (DDMM/YYYY)